{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:52:48Z","timestamp":1769601168857,"version":"3.49.0"},"reference-count":38,"publisher":"BMJ","issue":"Suppl","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"published-print":{"date-parts":[[1994,11,1]]},"DOI":"10.1136\/jnnp.57.suppl.50","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T22:20:59Z","timestamp":1226355659000},"page":"50-54","source":"Crossref","is-referenced-by-count":17,"title":["Indications for intravenous gammaglobulin therapy in inflammatory myopathies."],"prefix":"10.1136","volume":"57","author":[{"given":"P","family":"Cherin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Herson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00002281-199112000-00003","article-title":"The role of cell-mediated immunity in polymyositis","volume":"3","author":"Kalovidouris, A.E.","year":"1991","unstructured":"Kalovidouris AE. The role of cell-mediated immunity in polymyositis. Cur Op Rheumatol 1991;3:911-8.","journal-title":"Cur Op Rheumatol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-111-2-143","article-title":"Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis and related disorders","volume":"111","author":"Plotz, P.H.; Dalakas, M.; Leff, R.L.; Love, I.A.; Miller, F.W.; Cronin, M.E.","year":"1989","unstructured":"Plotz PH, Dalakas M, Leff RL, Love IA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis and related disorders. Ann Intern Med 1989;111:143-57.","journal-title":"Ann Intern Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-58-6-969","article-title":"Steroid therapy in patients with polymyositis and dermatomyositis","volume":"58","author":"Mulder, D.W.; Winkelmann, R.K.; Lambert, E.H.; Diessner, G.R.; Howard, F.M.","year":"1963","unstructured":"Mulder DW, Winkelmann RK, Lambert EH, Diessner GR, Howard FM. Steroid therapy in patients with polymyositis and dermatomyositis. Ann Int Med 1963; 58:969-76.","journal-title":"Ann Int Med"},{"key":"ref_4","first-page":"189","article-title":"Treatment of polymyositis and dermatomyositis","volume":"3","author":"Cherin, P.; Herson, S.; Godeau, P.","year":"1992","unstructured":"Cherin P, Herson S, Godeau P. Treatment of polymyositis and dermatomyositis. Europ Jf Intern Med 1992;3: 189-96.","journal-title":"Europ Jf Intern Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199201093260206","article-title":"Manipulating the immune system with immune globulin","volume":"326","author":"Dwyer, J.M.","year":"1992","unstructured":"Dwyer JM. Manipulating the immune system with immune globulin. NEnglJgMed 1992;326:107-16.","journal-title":"NEnglJgMed"},{"issue":"2","key":"ref_6","first-page":"116","article-title":"Intravenous immunoglobulin for polymyositis and dermatomyositis","volume":"336","year":"1990","unstructured":"Cherin P, Herson S, Wechsler B, Piette JC, Bletry 0, Ziza JM, Degennes C, Godeau P. Intravenous immunoglobulin for polymyositis and dermatomyositis. Lancet 1990;336(2):116.","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0002-9343(91)90009-M","article-title":"Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermnatomyositis: An open study with 20 adult patients","volume":"91","author":"Cherin, P.; Herson, S.; Wechsler, B.","year":"1991","unstructured":"Cherin P, Herson S, Wechsler B, et al. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermnatomyositis: An open study with 20 adult patients. Am J Med 1991;91:162-8.","journal-title":"Am J Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan, A.; Peter, J.B.","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis. N EnglJg Med 1975;292:344-7, 403-7.","journal-title":"N EnglJg Med"},{"key":"ref_9","article-title":"to the investigation of peripheral nerve injuries","author":"British Medical Research Council. Aids","year":"1943","unstructured":"British Medical Research Council. Aids to the investigation of peripheral nerve injuries, 2nd ed. London: HMSO, 1943.","edition":"2nd ed"},{"key":"ref_10","first-page":"156","article-title":"Physiopathogenie des dermatomyosites et des polymyosites: mise au point","volume":"141","author":"Cherin, P.; Herson, S.; Godeau, P.","year":"1990","unstructured":"Cherin P, Herson S, Godeau P. Physiopathogenie des dermatomyosites et des polymyosites: mise au point. Ann Mid Interne 1990;141:156-9.","journal-title":"Ann Mid Interne"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.32.6.536","article-title":"Methotrexate therapy in polymyositis","volume":"32","author":"Amett, F.C.; Welton, J.C.; Zizic, T.M.; Stevens, N.B.","year":"1973","unstructured":"Amett FC, Welton JC, Zizic TM, Stevens NB. Methotrexate therapy in polymyositis. Ann Rheum Dis 1973;32:536-46.","journal-title":"Ann Rheum Dis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.23.1.55","article-title":"Treatment of polymyositis with immunosuppressive drugs","volume":"23","author":"Haas, D.C.","year":"1973","unstructured":"Haas DC. Treatment of polymyositis with immunosuppressive drugs. Neurology 1973;23:55-62.","journal-title":"Neurology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(89)92456-2","article-title":"Cyclosporin in juvenile dermatomyositis","volume":"i:","author":"Heckmatt, J.; Hasson, N.; Saunders, C.","year":"1989","unstructured":"Heckmatt J, Hasson N, Saunders C, et al. Cyclosporin in juvenile dermatomyositis. Lancet 1989;i: 1063-6.","journal-title":"Lancet"},{"key":"ref_14","article-title":"Plasma exchange in polymyositis and dermatomyositis: a report of a multicenter study of 57 cases","author":"Cherin, P.; Pourrat, J.; Bussel, A.; Auperin, I.; Herson, S.","unstructured":"Cherin P, Pourrat J, Bussel A, Auperin I, Herson S. Plasma exchange in polymyositis and dermatomyositis: a report of a multicenter study of 57 cases (in press)."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(81)91567-1","article-title":"Polymyositis: remarkable response to total body irradiation (letter)","volume":"1","author":"Engel, W.K.; Lichter, A.S.; Galdi, A.P.","year":"1981","unstructured":"Engel WK, Lichter AS, Galdi AP. Polymyositis: remarkable response to total body irradiation (letter). Lancet 1981;1:658.","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"i:","author":"Imbach, P.; D'Appuzo, V.; Hirt, A.","year":"1981","unstructured":"Imbach P, D'Appuzo V, Hirt A, et al. High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;i: 1228-31.","journal-title":"Lancet"},{"key":"ref_17","article-title":"Immunologic thrombocytopenic purpura in HIVseropositive narcotic addicts","volume-title":"IV International Conference on AIDS","author":"Vespignagni, M.; Vaglia, A.; Chisesi, T.; Capnist, G.; Bressan, R.","year":"1988","unstructured":"Vespignagni M, Vaglia A, Chisesi T, Capnist G, Bressan R. Immunologic thrombocytopenic purpura in HIVseropositive narcotic addicts. IV International Conference on AIDS, 1988, Stockholm."},{"key":"ref_18","article-title":"High dose intravenous gammaglobulin for Kawasaki disease","author":"Furusho, K.; Sato, K.; Soeda, T.; Matsumoto, H.; Okabe, T.; Hirota, T.; Kawada, S.","year":"1983","unstructured":"Furusho K, Sato K, Soeda T, Matsumoto H, Okabe T, Hirota T, Kawada S. High dose intravenous gammaglobulin for Kawasaki disease. Lancet 1983;ii: 1359.","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1985.tb07430.x","article-title":"Successful response to intravenous immunoglobulin in auto-immune haemolytic anaemia","volume":"60","author":"MacIntyre, E.A.; Linch, D.C.; Macey, M.G.; Newland, A.C.","year":"1985","unstructured":"MacIntyre EA, Linch DC, Macey MG, Newland AC. Successful response to intravenous immunoglobulin in auto-immune haemolytic anaemia. Brit J Haemat 1985; 60:387-8.","journal-title":"Brit J Haemat"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(84)90469-0","article-title":"High dose intravenous gammaglobulin for myasthenia gravis","volume":"i:","author":"Gajdos, P.; Outin, H.; Elkharrat, D.","year":"1984","unstructured":"Gajdos P, Outin H, Elkharrat D, et al. High dose intravenous gammaglobulin for myasthenia gravis. Lancet 1984;i:406-7.","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1651-2227.1985.tb11039.x","article-title":"Gammaglobulin therapy in 6 newly diagnosed diabetic children","volume":"74","author":"Heinze, E.; Thon, A.; Vetter, U.; Gaedicke, G.; Zuppinger, K.","year":"1985","unstructured":"Heinze E, Thon A, Vetter U, Gaedicke G, Zuppinger K. Gammaglobulin therapy in 6 newly diagnosed diabetic children. Acta Ped Scand 1985;74:605-6.","journal-title":"Acta Ped Scand"},{"key":"ref_22","article-title":"Globulin treatment for lupus nephritis (LN), membranous nephropathy (MN), and membranoproliferative glomerulonephritis (MPGN), long term follow up study","volume-title":"Abstr 6th International Congress of Immunology, Toronto: 6-11","author":"Sugisaki, T.; Akagi, T.; Ito, S.; Kitazawa, K.; Uchida, J.; Saito, K.; Shibata, T.","year":"1986","unstructured":"Sugisaki T, Akagi T, Ito S, Kitazawa K, Uchida J, Saito K, Shibata T. Globulin treatment for lupus nephritis (LN), membranous nephropathy (MN), and membranoproliferative glomerulonephritis (MPGN), long term follow up study. Abstr 6th International Congress of Immunology, Toronto: 6-11 July, 1986;399."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/0002-9343(85)90213-X","article-title":"Human placenta-Eluted Gammaglobulins in Immunomodulating Treatment of Rheumatoid Arthritis","volume":"78","author":"Combe, B.; Cosso, B.; Clot, J.; Bonneau, M.; Sany, J.","year":"1985","unstructured":"Combe B, Cosso B, Clot J, Bonneau M, Sany J. Human placenta-Eluted Gammaglobulins in Immunomodulating Treatment of Rheumatoid Arthritis. Am Jf Med 1985;78:920-8.","journal-title":"Am Jf Med"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"Dutch Guillain-Barre Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome","volume":"326","author":"FG, Van Der Meche; PIM, Schmitz","year":"1992","unstructured":"Van Der Meche FG, Schmitz PIM, Dutch Guillain-Barre Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. N Engl Jf Med 1992;326: 1123-9.","journal-title":"N Engl Jf Med"},{"key":"ref_25","first-page":"385","article-title":"Traitement des neuropathies dysimmunitaires par immunoglobulines polyvalentes intraveineuses: etude ouverte de 16 cas","volume":"149","author":"Hoang-Xuan, K.; Leger, J.M.; Ben Younes-Chennoufi, A.; Saidi, H.; Bouche, P.; Baumann, N.; Brunet, P.","year":"1993","unstructured":"Hoang-Xuan K, Leger JM, Ben Younes-Chennoufi A, Saidi H, Bouche P, Baumann N, Brunet P. Traitement des neuropathies dysimmunitaires par immunoglobulines polyvalentes intraveineuses: etude ouverte de 16 cas. Rev Neurol 1993;149:385-92.","journal-title":"Rev Neurol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.1987.03400040111034","article-title":"Reversal of Chronic Polymyositis Following Intravenous Immune Serum Globulin Therapy","volume":"258","author":"Roifman, C.M.; Schaffer, F.M.; Wachsmuth, S.E.; Murphy, G.; Gelfand, E.W.","year":"1987","unstructured":"Roifman CM, Schaffer FM, Wachsmuth SE, Murphy G, Gelfand EW. Reversal of Chronic Polymyositis Following Intravenous Immune Serum Globulin Therapy. JAMA 1987;258:513-5.","journal-title":"JAMA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(91)90010-U","article-title":"Treatment of dermatomyositis with intravenous gammaglobulin","volume":"91","author":"Lang, B.A.; Laxer, R.M.; Murphy, G.; Silverman, E.D.; Roifman, C.M.","year":"1991","unstructured":"Lang BA, Laxer RM, Murphy G, Silverman ED, Roifman CM. Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 1991;91: 169-72.","journal-title":"Am J Med"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jnnp.55.1.60","article-title":"High-dose intravenous human immunoglobulin in polymyositis resistant to treatment","volume":"55","author":"Jann, S.; Beretta, S.; Moggio, M.; Adobbati, L.; Pellegrini, G.","year":"1992","unstructured":"Jann S, Beretta S, Moggio M, Adobbati L, Pellegrini G. High-dose intravenous human immunoglobulin in polymyositis resistant to treatment. J Neurol Neurosurg Psychiatry 1992;55:60-2.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref_29","first-page":"603","article-title":"Use of high dose intravenous immunoglobulins in the therapy of connectivitis: preliminary experience in 5 cases","volume":"82","author":"S, De Vita; A, D.'Ascanio; S, Bombardieri","year":"1991","unstructured":"De Vita S, D'Ascanio A, Bombardieri S. Use of high dose intravenous immunoglobulins in the therapy of connectivitis: preliminary experience in 5 cases. Recenti Prog Med 1991;82:603-6.","journal-title":"Recenti Prog Med"},{"key":"ref_30","first-page":"828","article-title":"The association of plasma exchange synchronized with intravenous gamma globulin in severe intractable polymyositis","volume":"19","author":"Herson, S.; Cherin, P.; Coutellier, A.","year":"1992","unstructured":"Herson S, Cherin P, Coutellier A. The association of plasma exchange synchronized with intravenous gamma globulin in severe intractable polymyositis. _J Rheumatol 1992;19:828-9.","journal-title":"_J Rheumatol"},{"key":"ref_31","first-page":"580","article-title":"Response of HIV-1-associated polymyositis to intravenous immunoglobulin","volume":"92","author":"Viard, J.P.; Vittecoq, D.; Lacroix, C.; Bach, J.F.","year":"1991","unstructured":"Viard JP, Vittecoq D, Lacroix C, Bach JF. Response of HIV-1-associated polymyositis to intravenous immunoglobulin. AmJMed 1991;92:580-1.","journal-title":"AmJMed"},{"key":"ref_32","first-page":"2215","article-title":"Efficacite des immunoglobulines intraveineuses sur l'atteinte musculaire au cours d'une sclerodermatomyosite","volume":"20","author":"Moraillon, I.; Cordoliani, F.; Rybojad, M.; Geoffray, C.; Morel, P.; Puissant, A.","year":"1991","unstructured":"Moraillon I, Cordoliani F, Rybojad M, Geoffray C, Morel P, Puissant A. Efficacite des immunoglobulines intraveineuses sur l'atteinte musculaire au cours d'une sclerodermatomyosite. Presse Mid 1991;20:2215-6.","journal-title":"Presse Mid"},{"key":"ref_33","first-page":"1092","article-title":"Intravenous gammaglobulin as first line therapy in polymyositis and dermatomyositis: a report of 11 cases","volume":"21","year":"1994","unstructured":"Cherin P, Piette JC, Wechsler B, Bletry 0, Ziza JM, Laraki R, Godeau P, Herson S. Intravenous gammaglobulin as first line therapy in polymyositis and dermatomyositis: a report of 11 cases. J Rheumatol 1994;21: 1092-7.","journal-title":"J Rheumatol"},{"key":"ref_34","article-title":"A controlled trial of high dose intravenous immune globulin, infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas, M.C.; Illa, I.; Dambrosia, J.M.","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high dose intravenous immune globulin, infusions as treatment for dermatomyositis. N Eng1J Med 1993;329: 1993-2000.","journal-title":"N Eng1J Med"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.4049\/jimmunol.136.12.4407","article-title":"Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use","volume":"136","author":"Stohl, W.","year":"1986","unstructured":"Stohl W. Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use. Jf Immunol 1986; 136:4407-13.","journal-title":"Jf Immunol"},{"key":"ref_36","first-page":"133","article-title":"Evidence of immunosuppression by high dose gammaglobulin","volume":"15","author":"Kawada, K.; Terasaki, P.I.","year":"1987","unstructured":"Kawada K, Terasaki PI. Evidence of immunosuppression by high dose gammaglobulin. Exp Hematol 1987;15: 133-6.","journal-title":"Exp Hematol"},{"key":"ref_37","first-page":"77","article-title":"Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia","volume":"108","author":"Engelhard, D.; Waner, J.L.; Kapoor, N.; Good, R.A.","year":"1986","unstructured":"Engelhard D, Waner JL, Kapoor N, Good RA. Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia. J7 Pediatr 1986;108: 77-81."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/1097-0142(19910915)68:6+<1430::AID-CNCR2820681405>3.0.CO;2-4","article-title":"Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases","volume":"68","author":"Ballow, M.","year":"1991","unstructured":"Ballow M. Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases. Cancer 1991;68: 1430-6.","journal-title":"Cancer"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.57.Suppl.50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:04:47Z","timestamp":1684627487000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.57.Suppl.50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11,1]]},"references-count":38,"journal-issue":{"issue":"Suppl","published-print":{"date-parts":[[1994,11,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.57.suppl.50","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1994,11,1]]}}}